Abnormal O-methylated dopamine metabolites: the endogenous toxins of schizophrenia or parkinsonism? 415 In spite of much work that would suggest the involvement of 3,4-dimethoxyphenethylamine (DMPEA) and its derivatives in either schizophrenia (Takesada, Kakimoto & others, 1963; Takesada, Miyamoto & others, 1965; Creveling & Daly, 1967) or in parkinsonism (Barbeau, de Groot & others, 1963), the issue remains confused, particularly when other reports claim DMPEA to be present in normal controls (Rinne & Sonninen, 1967) and only in small amounts in parkinsonian patients (Boulton & Felton, 1966).Although the original report of Friedhoff & Van Winkle (1962) that DMPEA is present in the pink spot of schizophrenic urine is now largely discredited, the transmethylation theory suggesting aberrant O-methylation still has wide support (Himwich, Narasimhachari & others, 1970). Indeed, both DMPEA and its N-acetyl derivative NADMPEA are known to produce behavioural changes in animals, the latter being the more potent (Bindler, Sanghvi & Gershon, 1968;Friedhoff & Schweitzer, 1968). Although these compounds possess the 4-methoxy group necessary for psychotomimetic activity, neither DMPEA nor NADMPEA produce the hallucigenic effects of the structurally similar mescaline when administered orally to man.In addition, reports claiming that DMPEA is present in parkinsonian urine have been supported by Ernst (1965), Barbeau, Tetreault & others (1966) and Shulgin, Sargent & Naranjo (1969) who showed in animal studies, used as a model for parkinsonism, that DMPEA, 3-hydroxy-4-methoxyphenethylamine (3HMPEA) and mescaline produced the characteristic akinesia in rats.A recent report by Barrass, Coult & Pinder (1972) showed that 3HMPEA but not the isomeric 4HMPEA nor DMPEA itself increased dopamine oxidation and inhibited 5-hydroxytryptamine (5-HT) oxidation in vitro. It was suggested, therefore, that 3HMPEA could be the endogenous toxin in parkinsonism producing akinesia and causing an imbalance in the dopamine: 5-HT ratio. Since DMPEA as well as 3HMPEA produces akinesia in lower animals, the position is clearly complicated. Also, in parkinsonism the substantia nigra, an area of the brain where the biochemical lesion could occur, is reported to be depleted of melanin deposit (Hornykiewicz, 1966) whereas increased dopamine oxidation would lead to increased melanin pigmentation.We wish to draw attention, therefore, to the contentious role of O-methylated derivatives of dopamine in schizophrenia and parkinsonism. The possibility must now be considered that such abnormal metabolites are involved in both diseases. We consider it plausible that 3HMPEA and DMPEA may play a dual role for the following reasons : (1) Both metabolites produce akinesia in animals and may conceivably thus produce the similar syndrome observed in parkinsonism.(2) Both DMPEA and the more potent NADMPEA effect behavioural changes in animals although neither appear to have the hallucigenic activity of mescaline. Although no evidence is yet available it is possibl...